Device Trial Radar · NCT06671561
Product Surveillance Registry; Ear, Nose and Throat - EXTEND Cohort
Last checked: Nov 19, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jan 30, 2025
Primary completion
Aug 2026
Study completion Apr 2027
Sponsor
- Lead sponsor
- MedtronicPublic (MDT)
- Sponsor type
- Industry
- First posted
- Nov 4, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to confirm long-term clinical safety and performance, acceptability of identified risks, and detect emerging risks based on factual evidence for the PROPEL family of products when used according to labeling in a real-world setting.
Conditions
- Chronic Rhinosinusitis (CRS)
Interventions
Observational data collection from patients with chronic rhinosinusitis (CRS) receiving PROPEL sinus implant(s) following functional endoscopic sinus surgery (FESS)Device
Observational data collection
Primary outcomes
What the sponsor says the trial is designed to measure.
- To characterize the SNOT-22 total score change from baseline to Month 6 in patients with CRS undergoing FESSTime frame: From baseline (prior to FESS procedure and sinus implant) to 6 months post procedure
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.